Literature DB >> 19603122

A metabonomic study of hepatitis B-induced liver cirrhosis and hepatocellular carcinoma by using RP-LC and HILIC coupled with mass spectrometry.

Peiyuan Yin1, Dafang Wan, Chunxia Zhao, Jing Chen, Xinjie Zhao, Wenzhao Wang, Xin Lu, Shengli Yang, Jianren Gu, Guowang Xu.   

Abstract

Liver cirrhosis and hepatocellular carcinoma (HCC) are fatal sequelaes of chronic hepatitis B in China. The sera from HCC and cirrhosis were profiled by rapid resolution liquid chromatography coupled with quadrupole time-of-flight (Q-TOF) mass spectrometry. Reversed-phased (RP) liquid chromatography and hydrophilic interaction chromatography (HILIC) were used for the data acquisition. The normalized and combined data were handled by chemometric analysis, and the combination proved to be effective and reliable for the orthogonal projection to latent structures (OPLS) analysis. Metabonomic profiles and the potential biomarkers were found based on the OPLS models. Shared and unique structure (SUS) plots were used for the evaluation of the potential biomarkers. Glycocholic acid, glycochenodeoxycholic acid, taurocholic acid and taurochenodesoxycholic acid were found to be potential biomarkers related to liver cirrhosis, while dihydrosphingosine and phytosphingosine were potential diagnostic biomarkers of HCC. The other identified metabolites were considered as common potential biomarkers for the two liver diseases. Correlation networks based on these metabolites were also built for the systemic understanding of these diseases and the possible biological implications are discussed. This metabonomic approach may provide insight into discovery and identification of new diagnostic biomarkers for liver cancer and associated diseases.

Entities:  

Mesh:

Year:  2009        PMID: 19603122     DOI: 10.1039/b820224a

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  63 in total

1.  Metabolomics reveals an essential role for peroxisome proliferator-activated receptor α in bile acid homeostasis.

Authors:  Fei Li; Andrew D Patterson; Kristopher W Krausz; Naoki Tanaka; Frank J Gonzalez
Journal:  J Lipid Res       Date:  2012-06-04       Impact factor: 5.922

Review 2.  Review of mass spectrometry-based metabolomics in cancer research.

Authors:  David B Liesenfeld; Nina Habermann; Robert W Owen; Augustin Scalbert; Cornelia M Ulrich
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-10-04       Impact factor: 4.254

3.  Serum Metabonomics of Mild Acute Pancreatitis.

Authors:  Hongmin Xu; Lei Zhang; Huan Kang; Jiandong Zhang; Jie Liu; Shuye Liu
Journal:  J Clin Lab Anal       Date:  2016-05-12       Impact factor: 2.352

4.  Plasma Lipid Profiling in a Rat Model of Hepatocellular Carcinoma: Potential Modulation Through Quinolone Administration.

Authors:  Mohamed I F Shariff; Joshua M Tognarelli; Matthew R Lewis; Elizabeth J Want; Fatma El Zahra Mohamed; Nimzing G Ladep; Mary M E Crossey; Shahid A Khan; Rajiv Jalan; Elaine Holmes; Simon D Taylor-Robinson
Journal:  J Clin Exp Hepatol       Date:  2015-07-18

5.  Bladder cancer determination via two urinary metabolites: a biomarker pattern approach.

Authors:  Zhenzhen Huang; Lin Lin; Yao Gao; Yongjing Chen; Xiaomei Yan; Jinchun Xing; Wei Hang
Journal:  Mol Cell Proteomics       Date:  2011-07-28       Impact factor: 5.911

6.  The Plasma and Serum Metabotyping of Hepatocellular Carcinoma in a Nigerian and Egyptian Cohort using Proton Nuclear Magnetic Resonance Spectroscopy.

Authors:  Mohamed I F Shariff; Jin Un Kim; Nimzing G Ladep; Asmaa I Gomaa; Mary M E Crossey; Edith Okeke; Edmund Banwat; Imam Waked; I Jane Cox; Roger Williams; Elaine Holmes; Simon D Taylor-Robinson
Journal:  J Clin Exp Hepatol       Date:  2017-03-15

7.  Human liver tissue metabolic profiling research on hepatitis B virus-related hepatocellular carcinoma.

Authors:  Shu-Ye Liu; Rikki-Lei Zhang; Hua Kang; Zhi-Juan Fan; Zhi Du
Journal:  World J Gastroenterol       Date:  2013-06-14       Impact factor: 5.742

Review 8.  The metabolomic window into hepatobiliary disease.

Authors:  Diren Beyoğlu; Jeffrey R Idle
Journal:  J Hepatol       Date:  2013-05-25       Impact factor: 25.083

9.  LC-MS based serum metabolomics for identification of hepatocellular carcinoma biomarkers in Egyptian cohort.

Authors:  Jun Feng Xiao; Rency S Varghese; Bin Zhou; Mohammad R Nezami Ranjbar; Yi Zhao; Tsung-Heng Tsai; Cristina Di Poto; Jinlian Wang; David Goerlitz; Yue Luo; Amrita K Cheema; Naglaa Sarhan; Hanan Soliman; Mahlet G Tadesse; Dina Hazem Ziada; Habtom W Ressom
Journal:  J Proteome Res       Date:  2012-11-01       Impact factor: 4.466

10.  Utilization of metabolomics to identify serum biomarkers for hepatocellular carcinoma in patients with liver cirrhosis.

Authors:  Habtom W Ressom; Jun Feng Xiao; Leepika Tuli; Rency S Varghese; Bin Zhou; Tsung-Heng Tsai; Mohammad R Nezami Ranjbar; Yi Zhao; Jinlian Wang; Cristina Di Poto; Amrita K Cheema; Mahlet G Tadesse; Radoslav Goldman; Kirti Shetty
Journal:  Anal Chim Acta       Date:  2012-07-20       Impact factor: 6.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.